欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Tyrosine Kinase-EGFR-ELF3-MED23 interaction inhibitor YK1
ELF3-MED23 interaction inhibitor YK1

Chemical Structure : ELF3-MED23 interaction inhibitor YK1

CAS No.: 915905-55-4

ELF3-MED23 interaction inhibitor YK1

货号: PC-24584Not For Human Use, Lab Use Only.

YK1 is a potent and selective PPI inhibitor for ELF3-MED23 with IC50 of 1.18 uM, 95 % inhibition at 10 uM, attenuates the HER2-mediated oncogenic signaling cascades.

规格 价格 库存 数量
50 mg Get quote
100 mg Get quote
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC)

生物&药学活性

YK1 is a potent and selective PPI inhibitor for ELF3-MED23 with IC50 of 1.18 uM, 95 % inhibition at 10 uM, attenuates the HER2-mediated oncogenic signaling cascades.
YK1 has IC50 of 0.91 uM and Ki of 0.78 uM in fluorescence polarization assays.
YK1 directly bind to MED23 via forming H-bonds with D400 and H449 residues.
YK1 specifically bound to MED23 391-462 region and interfered with the ELF3-MED23 PPI.
YK1 is specific to ELF3-MED23, does not disturb PPIs between MED23 and its known partner transcription factors, such as ELK1 and IRF7.
YK1 also not exhibit significant inhibitory activity against any of HER family kinases (EGFR, ErbB2, and ErbB4) or AKT/MAPK pathway-related kinases (PI3 kinase and c-RAF).
YK1 more potently inhibits the cell growth of NCI-N87, which highly expresses HER2 (IC50 = 1.56 μM), but almost non-cytotoxic in normal mammalian cells, indicating that the antiproliferative activity of YK1 is dependent on HER2 overexpression.
YK1 (4 mg/kg, i.v.) facilitated significant tumor growth retardation with significant reduction in tumor volume of NCI-N87 xenograft mice, also promoted apoptosis markedly in a dose-dependent manner.

物理化学性质&存储条件

分子量 314.77
分子式 C17H15ClN2O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1-(5-(4-chlorophenyl)-3-(3-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one

参考文献

1. Hwang SY, et al. J Adv Res. 2023 May;47:173-187.

2. Hwang SY, et al. Mol Cancer. 2025 May 9;24(1):139.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: